These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10460591)

  • 21. The expansion of megakaryocyte progenitors from CD34+-enriched mobilized peripheral blood stem cells is inhibited by Flt3-L.
    Case J; Hicks C; Trickett A; Kwan YL; Manoharan A
    J Interferon Cytokine Res; 2006 Feb; 26(2):76-82. PubMed ID: 16487027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood.
    Schipper LF; Brand A; Reniers NC; Melief CJ; Willemze R; Fibbe WE
    Br J Haematol; 1998 Jun; 101(3):425-35. PubMed ID: 9633882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
    Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
    Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biology of CD34+CD38- cells in lymphohematopoiesis.
    Novelli EM; Ramirez M; Civin CI
    Leuk Lymphoma; 1998 Oct; 31(3-4):285-93. PubMed ID: 9869192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
    Katayama Y; Mahmut N; Takimoto H; Maeda Y; Yano T; Kojima K; Azuma T; Hara M; Imajyo K; Takahashi S; Kai T; Ohno Y; Miyamoto T; Nagafuji K; Matsue K; Takenaka K; Teshima T; Shinagawa K; Ishimaru F; Omoto E; Harada M
    Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenoviral vector design for high-level transgene expression in primitive human hematopoietic progenitors.
    Fan X; Brun A; Karlsson S
    Gene Ther; 2000 Dec; 7(24):2132-8. PubMed ID: 11223995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.
    Wu MH; Smith SL; Dolan ME
    Stem Cells; 2001; 19(6):492-9. PubMed ID: 11713340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of human T-lymphoid progenitor cells in CD34+ CD38low and CD34+ CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ cultures.
    Robin C; Bennaceur-Griscelli A; Louache F; Vainchenker W; Coulombel L
    Br J Haematol; 1999 Mar; 104(4):809-19. PubMed ID: 10192444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells.
    Snoeck HW; Van Bockstaele DR; Nys G; Lenjou M; Lardon F; Haenen L; Rodrigus I; Peetermans ME; Berneman ZN
    J Exp Med; 1994 Sep; 180(3):1177-82. PubMed ID: 7520470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells.
    Fan X; Brun A; Segrén S; Jacobsen SE; Karlsson S
    Hum Gene Ther; 2000 Jun; 11(9):1313-27. PubMed ID: 10890741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo expansion of CD34 + CD38- cord blood cells.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; De Hemptinne D; Stryckmans P
    J Hematother; 1997 Apr; 6(2):93-102. PubMed ID: 9131438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine expansion culture of cord blood CD34+ cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions.
    Denning-Kendall P; Singha S; Bradley B; Hows J
    Stem Cells; 2003; 21(1):61-70. PubMed ID: 12529552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and molecular aspects of human CD34+ CD38- precursors: analysis of a primitive hematopoietic population.
    Xiao M; Dooley DC
    Leuk Lymphoma; 2000 Aug; 38(5-6):489-97. PubMed ID: 10953969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity in ex vivo expansion of cord blood myeloid progenitor cells before and after cryopreservation.
    Wang SY; Hsu ML; Huang MZ; Hsu HC; Tzeng CH; Hung JH; Ho CK
    Acta Haematol; 2001; 105(1):38-44. PubMed ID: 11340252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
    Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
    Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligation of CD38 suppresses human B lymphopoiesis.
    Kumagai M; Coustan-Smith E; Murray DJ; Silvennoinen O; Murti KG; Evans WE; Malavasi F; Campana D
    J Exp Med; 1995 Mar; 181(3):1101-10. PubMed ID: 7869031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells.
    Hanenberg H; Hashino K; Konishi H; Hock RA; Kato I; Williams DA
    Hum Gene Ther; 1997 Dec; 8(18):2193-206. PubMed ID: 9449373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
    Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
    Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay.
    Fortunel N; Hatzfeld J; Kisselev S; Monier MN; Ducos K; Cardoso A; Batard P; Hatzfeld A
    Stem Cells; 2000; 18(2):102-11. PubMed ID: 10742382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.